|Written||2007-06||Sally Ann Lynch|
|Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, NE1 4LP, UK|
|Other names||Currarino triad|
|Anal atresia, sacral anomalies, presacral mass (ASP)|
|Sacral defect with anterior meningocoele|
|Genes implicated in||MNX1|
|Note||Currarino syndrome is a multiple congenital anomalies syndrome characterized by partial agenesis of the sacrum in association with pelvic malformation. Anal atresia and the presence of a pre-sacral mass (teratoma and/or anterior meningocoele) make up the so called Currarino triad. Other malformations, such as renal (35%) and gynaecological (19%) are common. Hirschsprungs diseasehas also been recorded. Other rarer complications include pelvic abcess, malignant degeneration of a pre-sacral teratoma, E Coli ascending meningitis and spinal cord tethering. Recurrence of a benign teratoma has been recorded. Urinary incontinence, dysmenorrhoea, dyspareunia, poor sphincter control, sacral anaesthesia and headaches precipitated by coughing or straining have been reported.|
|Inheritance||Autosomal Dominant. De novo mutations have been recorded and account for approximately 15% of cases.|
|Note|| Currarino syndrome was described as a triad by Guido Currarino, an American radiologist in 1981. The triad consists of: |
The term Currarino syndrome is preferred as it is now known that there are other components to this genetic disorder. Bowel obstruction in infancy or chronic constipation in childhood are the commonest presenting symptoms. Gynaecological and renal malformation are commonly described. Hirschsprungs disease and meningitis (often E Coli ascending meningitis) have been recorded. Perianal sepsis, which is found in at least 10% of patients, can indicate the presence of an underlying presacral mass. Tumour development within the teratoma has been documented.
A report describing Currarino syndrome with ventriculomegaly due to a Arnold-Chiari type II malformation must be interpreted with caution. The affected child was dysmorphic with hypertelorism, a short enlarged neck and camptodactyly. The mother and brother also had Currarino syndrome without these added features. It is quite possible that this child had two co-existing disorders, one the Currarino inherited from a mother with typical features and secondly a de novo Arnold-Chiari type II malformation.
As with many dominant disorders the phenotype is very variable. It is estimated that approximately 50% of those who inherit the gene will present with the severe phenotype (requiring surgery), 25% will have symptoms albeit milder and 25% will be asymptomatic heterozygotes.
|Neoplastic risk|| The presacral mass associated with the Currarino triad may be a teratoma, hamartoma, neuroenteric cyst, anterior meningocoele or a combination of these three. |
A teratoma is a neoplasm originating from primordial germ cells and is derived from all three embryonal germ layers.
A hamartoma is a mass produced by disorganized local tissue growth and can contain all three germ layers.
A teratoma carries a risk for germ cell malignancy, a hamartoma does not.
It has been argued that the reason the risk for malignant degeneration in Currarino syndrome is low is because most of these pre-sacral masses which have previously been classified as teratomas are more likely to be hamartomas. In those rare instances where malignancy has been recorded it is possible that this could have resulted from a secondary carcinoma developing in a chronically inflamed hamartoma rather than a germ cell malignancy.
Malignant change of the pre-sacral tumour has been described but is a rare occurance. The histological appearances are varied and often poorly described particularly in the older literature.
A 32 year old women, who was known to have a pre-sacral teratoma, died from metastatic spread of the tumour. Histological findings were not included in the report (Ashcraft 1973; same patient also reported by Hunt, 1977).
A 54 year old male from a known Currarino family was diagnosed with a presacral mass. This was shown to be a teratoma which had undergone malignant change. A relative of this man, aged 14 years, who had been treated for a rectal stricture, died from a brain tumour, no histology was available. (Yates et al 1983).
A child who died from probable brain metastases was reported in a large Irish pedigree (O'Riordain et al 1991). Histology was not available and the child did not have a post mortem. This child had presented at birth with a pre-sacral mass and had surgery. The presacral teratoma recurred at aged 4 years and she died from a brain tumour shortly afterwards.
A female infant who had complete excision of a benign pre-sacral teratoma aged 14 months had a recurrence of a pre-sacral mass at aged 2 ( Tander et al 1999). Histology confirmed recurrence of the teratoma with malignant transformation. The AFP level was extremely high. Treatment was by excision and chemotherapy (bleomycin, etopside and cis-platin) but unfortunately the tumour recurred after 12 months She responded to the same course of chemotherapy but an aggressive recurrence at age 4 years did not respond to treatment and she died from pulmonary metastases.
A 22 year old male was reported who developed a malignant neuroectodermal tumour arising from a pre-sacral mass, (Urioste 2004). He had previously been asymptomatic. He presented with a painless abdominal swelling. A CT scan showed multiple cysts in the liver and it was thought he had isolated liver cystic disease. Lytic pelvic lesions were identified 1 year later on CT and a biopsy of one of these lesions confirmed a well differentiated neuroendocrine tumour. A presacral mass was identified in follow up scans suggestive of a presacral mass with malignant transformation. Biopsy of the mass and the liver confirmed the presence of a neuroendocrine tumour. Chemotherapy was ineffective and he subsequently died. Autopsy confirmed tumour invasion of the liver, pancreas, kidneys and mesenteric lympth nodes. The pre-sacral mass was comprised of neoplastic tissue, teratoma, muscle and fibroadipous tissue.
A 4 year old girl was reported with Currarino syndrome who developed an ectopic nephroblastoma and pulmonary metastases from a presacral mass (Martucciello G 2004). She died despite chemo and radiotherapy.
A 2 year old girl developed a malignant teratoma from a pre-existing presacral mass (Cretolle et al 2006). She was well following chemotherapy.
A 3 year old girl was reported with a malignant tumour arising within a teratoma (Sen et al 2006). Histology revealed the presence of two components; residual mature teratoma and a necrotic malignant tumour resembling a primitive peripheral neuroectodermal tumour. A chemotherapy regimen according to the Euro Ewing 99 protocol was given in addition to radiotherapy. She remained well 8 months following her treatment.
One report of leiomyosarcoma in a grandmother of an affected child with Currarino has been reported (Norum 1991).
In addition, a further case of Leiomyomatosis peritonealis disseminate (LPD) in a 27 year old female with Currarino syndrome has been described in the literature (Nappi 2006). Malignant degeneration of LPD to a leiomyosarcoma has been reported but is rare.
A sacrococcygeal teratoma has been described with a deletion of chromosome 7q, partial trisomy 2p. Malignant degeneration had not occurred and the child died from post-operative complications (Le Caignec 2003). This teratoma was a posterior teratoma and similar to the type often identified antenatally. It is thought to have a different genetic basis to the teratomas seen in the Currarino syndrome. No mutations in the HLXB9 gene have been found in such cases. It is therefore interesting that this child had deleted the HLXB9 gene suggesting some genetic relationship between both conditions.
In classical Currarino syndrome the pre-sacral mass tends to be anterior to the sacrum. The sacrococcygeal teratomas have appeared to be a different group in that they present in the posterior coccygeal region, are often sporadic, occur more commonly in females and commonly become malignant. Mutational analysis of the HLXB9 gene has been negative in a number of cases. This recent case is interesting as it does suggest that HLXB9 is involved in some cases of posterior teratomas (the gene was shown to be deleted in this case) in some cases.
|Treatment|| Symptomatic: those children who present at birth with imperforate anus will require emergency surgery. Surgery for the pre-sacral mass is usually advised. The mass can cause an obstruction or other symptoms such as ascending meningitis if an enteric fistula is present. There is also the risk of malignant transformation. Treatment of the mass if it undergoes malignant transformation involves both a surgical and chemothereputic approach. Bleomycin, etoposide and carboplatin are now the gold standard chemotherapeutic treatments. Carboplatin has recently replaced cisplatin as it is less nephro and ototoxic.|
Some patients may develop symptoms as a result of their renal or gynaecological malformation and these need to be managed appropriately. Spinal cord tethering is recognized and may recur requiring long term surveillance. Many individuals suffer from chronic constipation. Patients with a pre-sacral mass, particularly those with an anterior meningocoele, can develop headaches if pressure is increased within the abdominal cavity from coughing or sneezing or by lying on their abdomens.
|Evolution|| In those children where this condition is diagnosed at birth, a good clinical plus radiological assessment (including pelvic MRI) will identify most of the malformations. Surgery should be considered if a presacral mass is present. |
Many of the complications listed above can be avoided if appropriate action is taken in early childhood.
|Prognosis|| Generally very good. In some patients a colostomy bag is required for life. Some women can present symptoms from their gynaecological malformation and require assessment and occasionally treatment for this. Spinal cord tethering can be another debilitating problem that can recur despite treatment.|
If malignant transformation occurs chemotherapy can be effective but recurrences can occur which are resistant to treatment. There are no case reports recording a long remission but as the case reports are so few it is not possible to give definitive prognostic indicators. People have reported recurrence of a teratoma and therefore it is possible that malignancy could occur even if surgery has removed a presacral teratoma. However, the malignancy risk, which is already very small must be reduced even further by elective removal of any pre-sacral mass.
|Note||Cytogenetic analysis will be normal in most cases. However, some cases are associated with a 7q36 deletion or a translocation involving this region. It is worth considering FISH analysis of 7q36 in cases where Currarino syndrome is associated with developmental delay.|
|Cytogenetics of cancer||There is no information on the cytogenetic analysis of the pre-sacral tumours.|
|Genes involved and Proteins|
|Note||HLXB9 is a Homeobox gene. Proteins encoded by homeobox-containing genes are sequence-specific DNA binding proteins implicated in the control of gene expression in both developing and adult tissues.|
|Description||The HLXB9 gene has 3 exons. The phenotype results from haploinsufficiency of this gene.|
|Description|| The three exons encode a 403 amino acid protein containing a homeodomain preceded by a very highly conserved 82 amino acid domain. The remainder of the protein is not well conserved. This second highly conserved 82 amino acid domain encoded by HLXB9 may have a regulatory role and/or be involved in protein-protein associations. Amino acid substitutions in this area could conceivably give rise to different clinical phenotypes.|
There is a polyalanine region consisting of 16 alanines. There are population differences in the polyalanine domain but little correlation between the presence of disease or the variable penetrance of disease and the number of GCC repeats in patients.
|Expression|| In humans, studies have shown expression in the basal plate of the spinal cord and hindbrain and in the pharynx, oesophagus, stomach and pancreas and lymphoid tissue. Significant spatial and temporal expression differences were evident when expression of the gene in human and mouse were compared which may explain the phenotypic disparities observed between the two species.|
Tailbud expression has been noted in Xenopus laevis. Studies on human embryos demonstrated expression in the sacral region during embryogenesis albeit predominantly in the anterior horn regions of the spinal cord. In adults the HLXB9 gene is predominantly expressed in the pancreas.
A mouse model of the Currarino triad demonstrated that abnormal differentiation of the tail bud mesenchyme led to defects of the tailgut and neural tube. Etretinate (the teratogenic agent used) disrupted secondary neurulation and resulted in malformations resembling the Currarino triad. The cloacal plate appeared to play a critical role in the development of the anorectum and deficiencies of this caused anorectal malformation.
|Function||The HLXB9 gene functions as a transcription factor regulating gene expression in both developing and adult tissues. Little is known about target genes or protein partners.|
|Homology||The HLXB9 sequence shows up to 96%, 91% and 80% identity to orthologues in mouse, chick and Xenopus respectively. Sequence homology to Drosphilia homeobox genes and to the human homeobox gene PDX-1 suggest that some mutations within the HLXB9 homeodomain may alter the DNA binding specificity while other mutations may reduce nuclear translocation of the mutated protein.|
|Note|| Nonsense, frameshift and missense mutations have been identified. Most mutations are located within exon 1 and the homeodomain. Most missense mutations are clustered in the homeodomain whereas nonsense and frameshift mutations are mostly on the NH2 terminus of the protein. There is poor genotype phenotype correlation. Reduced penetrance has also been recorded by several groups. It appears, from in vitro assays that the missense mutations disrupt the binding of the homeodomain to the target DNA motif TAAT.|
Whilst mutations have been identified in almost all the familial cases, it appears that mutations are only found in 30% of sporadic cases. Somatic mosaicism is most favoured explanation. It is also possible that mutations might be present outside of the coding region and genetic heterogeneity remains a possiblity.
|Germinal||There have been no recorded cases of germ line mosaicism.|
|Somatic||There have been no recorded cases of somatic mosaicism.|
|Hereditary presacral teratoma.|
|Ashcraft KW, Holder TM|
|Journal of pediatric surgery. 1974 ; 9 (5) : 691-697.|
|Currarino syndrome shown by prenatal onset ventriculomegaly and spinal dysraphism.|
|Crétolle C, Sarnacki S, Amiel J, Geneviève D, Encha-Razavi F, Zrelli S, Zérah M, Nihoul Fékété C, Lyonnet S|
|American journal of medical genetics. Part A. 2007 ; 143 (8) : 871-874.|
|Triad of anorectal, sacral, and presacral anomalies.|
|Currarino G, Coln D, Votteler T|
|AJR. American journal of roentgenology. 1981 ; 137 (2) : 395-398.|
|Population differences in the polyalanine domain and 6 new mutations in HLXB9 in patients with Currarino syndrome.|
|Garcia-Barceló M, So MT, Lau DK, Leon TY, Yuan ZW, Cai WS, Lui VC, Fu M, Herbrick JA, Gutter E, Proud V, Li L, Pierre-Louis J, Aleck K, van Heurn E, Belloni E, Scherer SW, Tam PK|
|Clinical chemistry. 2006 ; 52 (1) : 46-52.|
|Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene.|
|Hagan DM, Ross AJ, Strachan T, Lynch SA, Ruiz-Perez V, Wang YM, Scambler P, Custard E, Reardon W, Hassan S, Nixon P, Papapetrou C, Winter RM, Edwards Y, Morrison K, Barrow M, Cordier-Alex MP, Correia P, Galvin-Parton PA, Gaskill S, Gaskin KJ, Garcia-Minaur S, Gereige R, Hayward R, Homfray T|
|American journal of human genetics. 2000 ; 66 (5) : 1504-1515.|
|Radiography of hereditary presacral teratoma.|
|Hunt PT, Davidson KC, Ashcraft KW, Holder TM|
|Radiology. 1977 ; 122 (1) : 187-191.|
|Spectrum of mutations and genotype-phenotype analysis in Currarino syndrome.|
|Köchling J, Karbasiyan M, Reis A|
|European journal of human genetics : EJHG. 2001 ; 9 (8) : 599-605.|
|Urodynamic evaluation in boys treated for posterior urethral valves.|
|Lal R, Bhatnagar V, Agarwala S, Grover VP, Mitra DK|
|Pediatric surgery international. 1999 ; 15 (5-6) : 358-362.|
|Prenatal diagnosis of sacrococcygeal teratoma with constitutional partial monosomy 7q/trisomy 2p.|
|Le Caignec C, Winer N, Boceno M, Delnatte C, Podevin G, Liet JM, Quere MP, Joubert M, Rival JM|
|Prenatal diagnosis. 2003 ; 23 (12) : 981-984.|
|Sharing of the same embryogenic pathway in anorectal malformations and anterior sacral myelomeningocele formation.|
|Liu Y, Sugiyama F, Yagami K, Ohkawa H|
|Pediatric surgery international. 2003 ; 19 (3) : 152-156.|
|Autosomal dominant sacral agenesis: Currarino syndrome.|
|Lynch SA, Wang Y, Strachan T, Burn J, Lindsay S|
|Journal of medical genetics. 2000 ; 37 (8) : 561-566.|
|Currarino syndrome: proposal of a diagnostic and therapeutic protocol.|
|Martucciello G, Torre M, Belloni E, Lerone M, Pini Prato A, Cama A, Jasonni V|
|Journal of pediatric surgery. 2004 ; 39 (9) : 1305-1311.|
|Leiomyomatosis peritonealis disseminata in association with Currarino syndrome?|
|Nappi C, Di Spiezio Sardo A, Mandato VD, Bifulco G, Merello E, Savanelli A, Mignogna C, Capra V, Guida M|
|BMC cancer. 2006 ; 6 : page 127.|
|Incomplete Currarino syndrome with a presacral leiomyosarcoma.|
|Norum J, Wist E, Bostad L|
|Acta oncologica (Stockholm, Sweden). 1991 ; 30 (8) : 987-988.|
|Hereditary sacral agenesis with presacral mass and anorectal stenosis: the Currarino triad.|
|O'Riordain DS, O'Connell PR, Kirwan WO|
|The British journal of surgery. 1991 ; 78 (5) : 536-538.|
|A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis.|
|Ross AJ, Ruiz-Perez V, Wang Y, Hagan DM, Scherer S, Lynch SA, Lindsay S, Custard E, Belloni E, Wilson DI, Wadey R, Goodman F, Orstavik KH, Monclair T, Robson S, Reardon W, Burn J, Scambler P, Strachan T|
|Nature genetics. 1998 ; 20 (4) : 358-361.|
|Familial Currarino syndrome presenting with peripheral primitive neuroectodermal tumour arising with a sacral teratoma.|
|Sen G, Sebire NJ, Olsen O, Kiely E, Levitt GA|
|Pediatric blood & cancer. 2008 ; 50 (1) : 172-175.|
|Malignant degeneration of presacral teratoma in the Currarino anomaly.|
|Urioste M, Garcia-Andrade Mdel C, Valle L, Robledo M, Gonz´lez-Palacios F, Méndez R, Ferreirós J, Nuño J, Benítez J|
|American journal of medical genetics. Part A. 2004 ; 128 (3) : 299-304.|
|Teratomas in the Currarino triad: a misnomer.|
|Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2000 ; 3 (1) : 110-111.|
|Anterior sacral defects: an autosomal dominantly inherited condition.|
|Yates VD, Wilroy RS, Whitington GL, Simmons JC|
|The Journal of pediatrics. 1983 ; 102 (2) : 239-242.|
|This paper should be referenced as such :|
|Atlas Genet Cytogenet Oncol Haematol. 2008;12(2):172-177.|
|Free journal version : [ pdf ] [ DOI ]|
|On line version : http://AtlasGeneticsOncology.org/Tumors/CurrarinoID10082.html|
|REVIEW articles||automatic search in PubMed|
|Last year articles||automatic search in PubMed|
|© Atlas of Genetics and Cytogenetics in Oncology and Haematology||indexed on : Fri Jun 30 11:24:14 CEST 2017|
For comments and suggestions or contributions, please contact us